معرفی
Professor Jennifer Wilkinson-Berka is an Adjunct Professor (Research) in the Department of Diabetes at Monash University, within the Faculty of Medicine, Nursing and Health Sciences. Her work is centered on understanding the pathogenesis of diabetic retinopathy (DR) and retinopathy of prematurity (ROP), with the goal of identifying new therapeutic targets.
Research Interests: Her research investigates the roles of vasoactive factors (particularly angiotensin II and aldosterone), oxidative stress (via Nox enzymes), and immune responses in retinal diseases. She uses animal models to study disease mechanisms and translate findings into clinical applications. Her work contributes to the UN Sustainable Development Goals related to health and well-being.
Recent Research Trends: Analysis of her recent publications reveals a strong focus on the renin-angiotensin-aldosterone system (RAAS), neuroinflammation, and oxidative stress in diabetic and developmental retinopathies. Her studies integrate molecular biology, immunology, and vascular physiology to explore multi-system interactions in disease progression.
Scientific Awards: No specific awards were mentioned in the provided text.
Advising and Grants: She has served as a Chief Investigator or Primary Chief Investigator on multiple research projects funded by organizations such as Diabetes Australia and Breakthrough T1D. These projects explore immune modulation, dietary interventions, and novel drug delivery systems for treating diabetic complications. While no students are explicitly named, her role as a supervisor indicates mentorship activities.
Labs and Teams: She leads a research team within the Department of Diabetes at Monash University and collaborates with a broad network of basic scientists, clinical researchers, and ophthalmologists, enabling rapid translation of findings from bench to bedside.
